Hydrocarbons

Published on 14/03/2015 by admin

Filed under Emergency Medicine

Last modified 22/04/2025

Print this page

rate 1 star rate 2 star rate 3 star rate 4 star rate 5 star
Your rating: none, Average: 0 (0 votes)

This article have been viewed 1805 times

152 Hydrocarbons

Pathophysiology

A hydrocarbon is an organic compound composed mainly of carbon and hydrogen atoms. In modern society, these compounds are virtually everywhere. Hydrocarbons are so common in our society that exposures—even illnesses related to exposures—are not usually documented. Hydrocarbons derive most commonly from distillation and processing of petroleum, but many derive from plants (pine oil, essential oils), animal fats, and natural gas. An example is gasoline, which is a mixture of alkanes, alkenes, naphthenes, and aromatic hydrocarbons. Commercial gasoline contains hundreds—up to 1500—individual chemical species.

The term solvent is often used to refer to an organic solvent—typically a hydrocarbon mixture—that is used to dissolve other substances. Occupational literature often uses the terms solvent and hydrocarbon interchangeably. Organic solvents are common in industry, and workers may suffer dermal or inhalational exposures. Children may suffer unintentional hydrocarbon exposures, often ingestions, with a risk of pulmonary hydrocarbon aspiration. More concerning is a trend toward greater intentional abuse of volatile hydrocarbon inhalants by adolescents and young adults. This form of substance abuse, often termed volatile substance abuse (VSA), is a growing problem worldwide.

One can predict many of the physical properties of hydrocarbons by knowing the molecular shape and size (number of carbon atoms in the molecule’s chain). The nonpolar, covalent bonds between carbon-carbon and carbon-hydrogen atoms produce dispersion forces, which result in the attraction between hydrocarbon molecules. These same forces repel polar molecules (e.g., water) and make hydrocarbons generally hydrophobic. Once dissolved in aqueous solution, nonpolar hydrocarbons can transit rapidly through lipid membranes, including cell membranes and the blood-brain barrier. Small, light, aliphatic hydrocarbons with up to 4 carbons are gases at room temperature; those with 5 to 19 carbon molecules are liquids; and longer molecules form solids or paraffins. Branching in the molecule destabilizes intermolecular forces, so less energy is required to separate molecules. This makes it easier for a molecule to leave the liquid phase and enter the vapor phase (to volatilize). Therefore, for a given molecular size, more branching means a lower boiling point, and the compound is typically more volatile. Gaseous or volatilized hydrocarbons are likely to cause toxicity by inhalation.

Lipid-soluble solvents (aromatic, aliphatic, or halogenated hydrocarbons) are more likely than water-soluble hydrocarbons (alcohols, ketones, or esters) to cause acute central nervous system (CNS) effects. Clinicians are familiar with these effects from experience with inhaled anesthetic agents, which cause CNS sedation similar to that resulting from other hydrocarbons. The Meyer-Overton hypothesis suggests that inhaled anesthetics dissolve into some critical lipid compartment of the CNS and cause generalized inhibition of neuronal transmission. This mechanism is probably oversimplified, but it helps to explain partly the nonspecific inhibition of neuronal transmission that hydrocarbons produce in the CNS. Specific membrane interactions may also contribute to this process,1 and several receptor-mediated interactions are known to occur.

Specific physical properties of ingested hydrocarbons help to predict the risk of pulmonary aspiration (Table 152.1). In particular, viscosity, surface tension, and volatility determine aspiration potential and the contribution to pulmonary toxicity.2 Viscosity is a measure of a fluid’s resistance to flow, commonly described in units of Saybolt universal seconds (SUS). This property is not the same as the fluid’s density; in fact, these two properties correlate poorly.

Low-viscosity substances (less than 60 SUS), such as turpentine, gasoline, or naphtha, have higher tendency for aspiration in animal models. A lower viscosity value predicts a higher risk. The U.S. Consumer Products Safety Commission now requires child-resistant packaging for products that contain 10% or more hydrocarbons and have a measured viscosity less than 100 SUS.

Surface tension indirectly measures dispersion forces between molecules in a fluid, but it also characterizes the interaction with the surface that the fluid contacts. This property can be quantified on a modified Wilhelmy balance, which measures adherence of the fluid along a surface (“the inability to creep”). In theory, the lower the surface tension is, the higher is the aspiration risk.2 A lower surface tension value predicts a higher risk.

Volatility is the tendency for a liquid to enter the gas phase. Hydrocarbons that are highly volatile have a high vapor pressure and so tend to vaporize, enter the lungs, displace oxygen, and cause hypoxia. A higher volatility value predicts a higher risk.

Mechanisms of Toxicity

Although organ-specific pathophysiology is often unique to individual agents, much of the toxicity of hydrocarbons results from their ability to dissolve fats or, similarly, to diffuse across hydrophobic barriers intended to protect anatomic structures (e.g., lipid bilayers, myelin). Hydrocarbon solvents cause irritation of skin and mucous membranes. Recurrent or prolonged contact results in “defatting” of skin, dissolving lipid components, and disrupting the normal architecture of the stratum corneum.3

Most hydrocarbons are flammable or combustible. Under appropriate conditions, most hydrocarbons can explode. The widespread availability of hydrocarbons and their use as organic solvents account for the frequent finding of stored quantities of these solvents in clandestine illicit drug laboratories and other places. Storage and use of these flammable agents appreciably contribute to the health hazards of these facilities.

Cardiac Effects

Many hydrocarbons are acutely cardiotoxic. Especially important is their propensity to induce tachyarrhythmias. The mechanism by which hydrocarbons cause malignant rhythms is poorly characterized, but some of these agents can precipitate ventricular tachycardia or fibrillation and can cause sudden death.

Endogenous or exogenous catecholamines (e.g., epinephrine) are proarrhythmic. Hydrocarbons enhance this potential and are said to sensitize the myocardium to the arrhythmogenic effects of catecholamines. Essentially every class of hydrocarbon compounds, including general anesthetic agents, can sensitize the heart. Some classes carry a high risk, however, and others sensitize the myocardium modestly, if at all. The ability of these substances to sensitize the heart constitutes an accepted system for grading halocarbon (e.g., Freon) toxicity. Unsaturated, aliphatic hydrocarbons (e.g., ethylene) and aliphatic ethers have been studied but do not appear to be sensitizers. Other unsaturated compounds (e.g., acetylene), are weak sensitizers. Aromatic hydrocarbons and, especially, halogenated hydrocarbons are often potent sensitizers.6

Sensitization appears to be mediated by slowed conduction velocity, possibly by chemical and functional changes in the membrane transport proteins at gap junctions. The major ventricular gap junction protein is composed of connexin 43. This protein is regulated by phosphorylation, such that the dephosphorylated state of the hexamers in the channel is associated with greater gap junction resistance. In the presence of epinephrine, halocarbons increase gap junction resistance in myocardial tissue and slow conduction velocity.7

Nervous System Effects

The mechanism by which hydrocarbons depress consciousness is unknown. Diffusion across the blood-brain barrier with neuronal membrane stabilization provides the foundation of the Meyer-Overton hypothesis. To date, no specific receptor wholly explains this generalized effect. In cases of pulmonary toxicity, hypoxemia may contribute to depressed consciousness.8

Chronic solvent abuse leads to irreversible CNS toxicity, best described in the setting of toluene abuse. Volitional abusers demonstrate loss of cerebral white matter, with a characteristic syndrome of cognitive and motor deficits. Autopsied brains of long-term toluene abusers show profound atrophy and mottling of the white matter, as though the lipid-based myelin had been dissolved away. Microscopic examination shows a consistent pattern of demyelination, with relative preservation of axons. These pathologic features correlate with the clinical syndrome of subcortical dementia.9 Mild cognitive deficits show improvement after 6 months of abstinence. In patients with advanced disease, regardless of the exposure history, full recovery is unlikely.10

Exposure to n-hexane or to methyl n-butyl ketone (MnBK) can cause peripheral neuropathy. This toxic axonopathy appears to result from 2,5-hexanedione, a metabolic intermediate common to both agents. The mechanism appears to involve decreased phosphorylation of neurofilament proteins, with disruption of the axonal cytoskeleton.11

Radiologically and histopathologically, prolonged and repeated exposures to toluene are associated with brain demyelination. Although the mechanism of this process is not fully understood, it is presumed to result from dissolution of myelin by the solvent. Toluene encephalopathy is characterized by a specific constellation of findings, alternatively described as “subcortical dementia,” “white matter dementia,” or “toxic leukoencephalopathy.” Findings include the following: loss of cortical gray matter–white matter differentiation; atrophic changes in the basal ganglia, cerebellum, pons, and thalamus; and thinning of the corpus callosum. Changes noted on magnetic resonance imaging appear to progress in a lifetime dose–dependent fashion.12 Unfortunately, toluene is an addictive substance, and progression of abnormalities is likely with persistent use. Resolution of neurologic abnormalities has not been documented once white matter loss becomes radiographically evident. Complete recovery from solvent encephalopathy is not considered likely, even with abstinence or removal from exposure.10

Presenting Signs and Symptoms

The route of exposure considerably influences the organs affected. The principal organ systems affected by hydrocarbons are the skin (from dermal contact), the GI system (when ingested), the CNS, and the lungs. Some classes of hydrocarbons are cardiotoxic. Certain agents may cause organ-specific toxicity to cranial or peripheral nerves, the liver, or the kidneys. Typical presenting symptoms can be found in Table 152.2.

Table 152.2 Symptoms Associated with Hydrocarbon Exposure

Symptom Notes
Coughing, choking, or vomiting Heightens suspicion of pulmonary aspiration
Behavioral changes, impaired sense of smell, impaired concentration, and mildly unsteady movements or gait Transient excitation initially possible after inhalation or ingestion, but early sedation more common
Elevated temperature Initially noted in hydrocarbon aspiration
Often spiking at 8 to 12 hours and then declining over several days, unless bacterial superinfection occurs
Drying, cracking, pitting, or eczematous lesions Contact dermatitis or frostbite injury with intentional abuse
Muscle weakness Renal tubular acidosis associated with hypokalemia, with consequent muscle weakness or arrhythmia, possibly the presenting complaint
Seizures Uncommon, probably because of overwhelming anesthetic effects, and should raise suspicion of a coingestant
Exceptions: (1) seizures that occur after large ingestion of pine oil or essential oils (e.g., oil of wormwood, fennel oil) and (2) anoxic seizures
Persistent hypoxia Methemoglobinemia, carbon monoxide toxicity, and blood dyscrasias associated with specific ingestions
Peripheral neuropathy Beginning in distal extremities and progressing proximally

The intentional inhalation in VSA can be challenging to diagnose because affected patients frequently withhold relevant history. Several common inhalational techniques have been identified. Sniffing involves inhaling vapor from an open container. Huffing involves placing a volatile hydrocarbon in a rag or cloth, then covering the nose and mouth with the cloth or rag and inhaling the agent through it. Bagging implies placing the substance inside a plastic (or other) bag and then putting the bag over the face to inhale hydrocarbon vapor.

Respiratory findings are uncommon after inhalation, but the patient may manifest tachypnea or cyanosis or may suffer sudden cardiac arrest. Classically, cardiac arrest occurs after a sudden fright or physical exertion (e.g., running to avoid an authority), with a sudden catecholamine surge and a sensitized heart. This phenomenon is termed the sudden sniffing death syndrome.

Cutaneous findings may be the chief complaints, with dermal exposure to solvents from work or hobbies. Drying, cracking, pitting, or eczematous lesions occur in up to 9% of workers who are repeatedly exposed. Allergic reactions are uncommon but may be seen with exposure to certain essential oils or to pine oil. Nonspecific skin irritation is the most common finding, and it may progress to blistering or contact dermatitis with recurrent, prolonged, or protracted VSA. With continued or recurring exposure, the skin changes may even progress to partial- or even full-thickness chemical burns.4 When the dermatitis involves the skin surrounding the nose and mouth, it has been dubbed “huffer’s rash” (Fig. 152.1). Abusers of volatile solvents may have telltale paint, shoeshine, or solvent stains on clothes or skin. Nonfreezing cold injury (frostbite) may occur on or about the face because of intentional release of liquid hydrocarbon propellant, which cools as it suddenly exits its container (Fig. 152.2).

Hydrocarbons cause CNS depression. Transient excitation may initially occur after inhalation or ingestion, but early sedation is more common. Initial findings include behavioral changes, impaired sense of smell, impaired concentration, and mildly unsteady movements or gait. As with alcohol or other sedatives, mild exposures produce euphoria, likely contributing to abuse potential. Further acute exposure leads to slurred speech and progressive incoordination. Physical signs are nystagmus, tremor, spasticity with hyperreflexia, abnormal plantar reflexes, hearing loss, impaired vision, and a broad-based, staggering gait. Pain inhibition explains why hydrocarbons were chosen as general anesthetic agents. Stupor, lethargy, or obtundation is seen in overdose. Coma and seizures occur in up to 3% of cases.14

Chronic CNS dysfunction occurs in recurrent abusers of volatile substances, and reports include optic neuropathy, sensorineural hearing loss, equilibrium disorders, ataxia, and cognitive deficits. Occupational solvent exposures are also associated with persistent CNS abnormalities, although the exposures and the clinical findings are typically less impressive than those in habitual VSA. Most published reports involve exposure to toluene, a very common workplace and household hydrocarbon solvent. Neurologic deficits are tremor, ataxia, impaired fine-motor skills, and mild cognitive defects. Long-term occupational exposures are associated with a clinical syndrome consisting of fatigue, poor short-term memory, attention difficulties, visuospatial abnormalities, personality changes, and mood disorder. Clinically, this presentation has been dubbed “the painter’s syndrome.”

Abdominal pain and vomiting are common, and diarrhea is likely after ingestion, particularly of insoluble hydrocarbons (mineral oil, paraffins). Vomiting increases the risk of pulmonary aspiration.

A typical case in the emergency department (ED) involves a young child who is suspected to have unintentionally ingested a hydrocarbon mixture. Infrequently, a parent may have witnessed the ingestion; more typically, the situation was discovered shortly thereafter. The caregiver often identifies the specific agent. A parent may report that the child was coughing, gagging, or vomiting, or that he or she noticed an odor of the suspected hydrocarbon. If the ingestion was unwitnessed, it may be difficult to quantify the amount ingested, but a “worst case scenario” can often be ascertained. A history of coughing, choking, or vomiting should heighten the ED’s suspicion of pulmonary aspiration. Respiratory findings include coughing, choking, gagging, grunting, tachypnea, retractions, fever, cyanosis or poor coloration, and abnormal sounds on chest auscultation. Mental status depression is common in patients with larger ingestions but may not occur for 30 to 60 minutes after ingestion. In a prospective, multicenter study of 760 pediatric kerosene ingestions, no association was found between the age of the patient and the amount ingested. The risks of pulmonary toxicity and of CNS depression were significantly higher in children who ingested more than 30 mL of kerosene (according to history). The incidence of pulmonary aspiration was higher in children who vomited after ingestion.15

Differential Diagnosis and Medical Decision Making

The differential diagnosis in hydrocarbon exposure is usually limited because the history often elucidates the exposure. Some possible differential diagnoses include adult respiratory distress syndrome, toxic alcohol exposure, barbiturate or benzodiazepine toxicity, and toluene exposure.

The diagnostic evaluation of a patient with hydrocarbon exposure depends heavily on the known patterns of toxicity associated with specific hydrocarbon agents and the route of exposure. It is more crucial to obtain and verify the history, with particular attention to identifying the specific type and composition of the agent or agents involved. The route of exposure should direct the clinician to the anticipated target organ or organs, which guide testing.

Renal function, serum electrolyte levels, and acid-base status should be evaluated in all patients with a history of chronic or recurrent toluene exposure. Liver transaminases and bilirubin should be assayed in patients with significant exposure to halocarbons or to benzene. Electrocardiographic monitoring and a formal 12-lead electrocardiogram are indicated when a patients has significant exposure to heart-sensitizing hydrocarbon agents. Head computed tomography and magnetic resonance imaging are valuable to assess the extent of brain involvement in chronic exposures. Pulse oximetry or arterial blood gas testing helps assess the severity of pulmonary injury. Carboxyhemoglobin or methemoglobin measurements are indicated for exposures involving specific agents (see “Other Effects”).

Early chest radiography may be indicated for severely symptomatic patients, to gauge the extent of pulmonary injury and guide the inpatient placement decision. Radiographic evidence of pneumonitis may develop as early as 15 minutes or as late as 24 hours after hydrocarbon aspiration. Ninety percent of patients who have radiographic abnormalities do so within 4 hours.16 After the initial episode of coughing, gagging, or choking, most patients with persistent respiratory signs and symptoms have pneumonitis and radiographic changes. Typical findings in hydrocarbon pneumonitis are audible abnormalities on chest auscultation, fever, leukocytosis, and abnormalities on chest radiograph (Fig. 152.3). These findings do not differ clinically from those of community-acquired pneumonia. Only the history differentiates the two entities. The elevated temperature initially noted in hydrocarbon aspiration often spikes at 8 to 12 hours, then declines over several days, unless bacterial superinfection intervenes. For an asymptomatic patient with hydrocarbon ingestion, however, early radiography does not help predict aspiration pneumonitis, and it is not cost-effective.

Results of bioassays and serum hydrocarbon levels are rarely available to the emergency physician and have little to no value in management of hydrocarbon exposure. These measurements are available through reference laboratories for occupational monitoring or to document exposure in forensic cases.

Treatment

Decontamination

An algorithm for the treatment of hydrocarbon exposure is shown in Figure 152.4. The first priority in managing toxicity is to protect rescuers. Personal protection is paramount at each level of health care delivery. Second, the exposure should be removed from the patient, and the patient should be removed from the exposure. Contaminated clothing and external contamination must be removed before the patient enters any patient care or trafficked area. For most hydrocarbons, soap and water are all that are required for decontamination. Most hydrocarbons are flammable and pose a fire risk to the hospital and staff. Personal protective equipment should be worn by anyone who will touch the patient or any articles brought with the patient. Once the patient is externally decontaminated, standard precautions generally suffice in the ED.

Gastric emptying may be useful when the hydrocarbon is extremely toxic (e.g., carbon tetrachloride), when a large volume of hydrocarbon is ingested (more than 30 mL), or when severe toxicity is predicted (Box 152.1). If gastric lavage is performed, a small-bore (not large-bore) nasogastric tube should be used, to reduce the risk of vomiting and aspiration. Activated charcoal has little ability to reduce GI absorption of hydrocarbons and may cause gastric distention and vomiting. Any role for activated charcoal in isolated hydrocarbon ingestion is limited, at best.

Most hydrocarbons cannot be removed by dialysis, but toxic agents that are water-soluble, small, highly polar molecules can be removed by dialysis. Examples are small alcohols and polyols (e.g., methanol, ethylene glycol). Small ketones (e.g., acetone) are also dialyzable. Chloral hydrate can be successfully removed by hemodialysis. Peritoneal dialysis has been employed to reduce the toxicity of both dichloroethane and trichloroethylene. Unfortunately, many hydrocarbon molecules are too large to be dialyzed. Most are lipophilic, so they dissolve into fat stores (with greater volume of distribution), thus reducing their availability in the central compartment.

Extracorporeal membrane oxygenation can successfully temporize the course of severe pulmonary toxicity. This technique is considered invasive, is not widely available, and requires special expertise. Use of extracorporeal membrane oxygenation is generally reserved for severe cases of hydrocarbon toxicity for which other available modalities have failed to achieve adequate oxygenation.

Resuscitation

Priorities of resuscitation are similar to those in any other type of poisoning. Nuances include the requirement to limit exposure of the patient and caregivers by prioritizing decontamination. The airway and systemic oxygenation should be restored and secured first. This should be achieved by any necessary means and may require high-flow oxygenation, endotracheal intubation, ventilation, and the use of bronchodilators. Positive end-expiratory pressure (PEEP) ventilation may help oxygenate patients who are persistently hypoxemic. High-frequency jet ventilation may be required and has been used successfully in this situation.

Dysrhythmias in the setting of hydrocarbon toxicity should prompt investigations into electrolyte and acid-base status, hypoxemia, hypotension, and hypothermia. Ventricular fibrillation is especially concerning because resuscitation algorithms recommend epinephrine to treat this rhythm. If the dysrhythmia can be ascertained to emanate from myocardial sensitization by a solvent, catecholamines should be avoided. Exogenous catecholamines (e.g., epinephrine) should be avoided. In this setting, lidocaine has been used successfully, as have beta-blockers.17,18

Management of hypotension may be precarious. Hydrocarbons do not generally affect systemic vascular resistance, so coingestants should be considered in the persistently hypotensive patient. Hypotension may relate to excessive PEEP, and reducing PEEP may improve hemodynamics. Rarely, some hydrocarbons can cause myocardial depression; in a patient with this finding, an inotrope (but not isoproterenol or dobutamine) should be considered. Pressors such as dopamine, epinephrine, isoproterenol, and norepinephrine must be avoided, if possible, because of the risk of myocardial sensitization.6

References

1 Sikkema J, de Bont JA, Poolman B. Mechanisms of membrane toxicity of hydrocarbons. Microbiol Rev. 1995;59:201–222.

2 Gerarde HW. Toxicological studies on hydrocarbons. IX. The aspiration hazard and toxicity of hydrocarbons and hydrocarbon mixtures. Arch Environ Health. 1963;6:329–341.

3 Lupulescu AP, Birmingham DJ. Effect of protective agent against lipid-solvent–induced damages: ultrastructural and scanning electron microscopical study of human epidermis. Arch Environ Health. 1976;31:33–36.

4 Hansbrough JF, Zapata-Sirvent R, Dominic W, et al. Hydrocarbon contact injuries. J Trauma. 1985;25:250–252.

5 Bratton L, Haddon JE. Ingestion of charcoal lighter fluid. J Pediatr. 1975;87:633–636.

6 Brock WJ, Rusch GM, Trochimowicz HJ. Cardiac sensitization: methodology and interpretation in risk assessment. Regul Toxicol Pharmacol. 2003;38:78–90.

7 Jiao Z, De Jesus VR, Iravanian S, et al. A possible mechanism of halocarbon-induced cardiac sensitization arrhythmias. J Mol Cell Cardiol. 2006;41:698–705.

8 Wolfsdorf J. Kerosene intoxication: an experimental approach to the etiology of the CNS manifestations in primates. J Pediatr. 1976;88:1037–1040.

9 Kornfeld M, Moser AB, Moser HW. Solvent vapor abuse leukoencephalopathy: comparison to adrenoleukodystrophy. J Neuropathol Exp Neurol. 1994;53:389–398.

10 Triebig G, Hallermann J. Survey of solvent related chronic encephalopathy as an occupational disease in European countries. Occup Environ Med. 2001;58:575–581.

11 Graham DG. Neurotoxicants and the cytoskeleton. Curr Opin Neurol. 1999;12:733–737.

12 Rosenberg NL, Grigsby J, Dreisbach J, et al. Neuropsychologic impairment and MRI abnormalities associated with chronic solvent abuse. J Toxicol Clin Toxicol. 2002;40:21–34.

13 Voigts A, Kaufman CE. Acidosis and other metabolic abnormalities associated with paint sniffing. South Med J. 1983;76:443–477. 452

14 Kulig K, Rumack B. Hydrocarbon ingestion. Curr Top Emerg Med. 1981;3:1–5.

15 Press E. Cooperative kerosene poisoning study: evaluation of gastric lavage and other factors in the treatment of accidental ingestion of petroleum distillate products. Pediatrics. 1962;29:648–674.

16 Daeschner CW, Blattner RJ, Collins VP. Hydrocarbon pneumonitis. Pediatr Clin North Am. 1957;4:243–253.

17 Moritz F, de La Chapelle A, Bauer F, et al. Esmolol in the treatment of severe arrhythmia after acute trichloroethylene poisoning [letter]. Intensive Care Med. 2000;26:256.

18 Zahedi A, Grant MH, Wong DT. Successful treatment of chloral hydrate cardiac toxicity with propranolol. Am J Emerg Med. 1999;17:490–491.

19 Anas N, Namasonthi V, Ginsburg CM. Criteria for hospitalizing children who have ingested products containing hydrocarbon. JAMA. 1981;246:840–843.